# Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)

> **NCT06714097** · NA · RECRUITING · sponsor: **Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta** · enrollment: 20 (estimated)

## Conditions studied

- Stroke
- Moyamoya Disease
- Cerebral Amyloid Angiopathy

## Interventions

- **DEVICE:** AI
- **OTHER:** healthy dialogue

## Key facts

- **NCT ID:** NCT06714097
- **Lead sponsor:** Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06714097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06714097, "Application of Digital Twins' Technology in Patients Who Had a Stroke, With Moyamoya Disease and With Cerebral Amyloid Angiopathy (CAA) During the Secondary Prevention Phase: A Proof of Concept Using a Randomized Control Trial (Clinical Study 6, STRATIF-AI Project)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06714097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*